{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:36:02Z","timestamp":1791218162305,"version":"4.1.0"},"reference-count":44,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,8,14]],"date-time":"2007-08-14T00:00:00Z","timestamp":1187049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Nephrology"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:title>SUMMARY:<\/jats:title><jats:p><jats:bold>Aims:\u2003<\/jats:bold> To determine if rates of diabetic and non\u2010diabetic end\u2010stage renal disease (ESRD), which had been rising in young and middle\u2010aged adults in all populations up to the mid\u20101990s, had started to decline, and if so, whether improvement had occurred in respect of each of the principal primary renal diseases causing ESRD.<\/jats:p><jats:p><jats:bold>Methods:\u2003<\/jats:bold> Poisson regression of age\u2010 and sex\u2010standardized incidence of ESRD for persons aged 20\u201364\u2003years in 18 populations from Europe, Canada and the Asia\u2010Pacific region, for 1998\u20132002.<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold> In persons from 12 European descent (Europid) populations combined, there was a small downward trend in all\u2010cause ESRD (\u22121.7% per year, <jats:italic>P<\/jats:italic>\u2003=\u20030.001), with type 1 diabetic ESRD falling by 7.8% per year (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001), glomerulonephritic ESRD by 3.1% per year (<jats:italic>P\u2003<\/jats:italic>=\u20030.001), and \u2018all other non\u2010diabetic\u2019 ESRD by 2.5% per year (<jats:italic>P\u2003<\/jats:italic>=\u20030.02). The reductions in ESRD attributed to hypertensive (\u22122.2% per year) and polycystic renal disease (\u22121.5% per year) and unknown diagnosis (\u22120.2% per year) were not statistically significant. On the other hand, the incidence of type 2 diabetic ESRD rose by 9.9% per year (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001) in the combined Europid population, although that of (principally type 2) diabetic ESRD remained unchanged in the pooled data from the four non\u2010Europid populations.<\/jats:p><jats:p><jats:bold>Conclusion:\u2003<\/jats:bold> Recent preventive strategies, probably chiefly modern renoprotective treatment, appear to have been effective for tertiary prevention of ESRD caused by the proteinuric nephropathies other than type 2 diabetic nephropathy, for which the continuing increase in Europid populations represents a failure of prevention and\/or a change in the nephropathic potential of type 2 diabetes.<\/jats:p>","DOI":"10.1111\/j.1440-1797.2007.00830.x","type":"journal-article","created":{"date-parts":[[2007,8,16]],"date-time":"2007-08-16T23:54:45Z","timestamp":1187308485000},"page":"520-527","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Trends in incidence of treated end\u2010stage renal disease, overall and by primary renal disease, in persons aged 20\u201364\u2003years in Europe, Canada and the Asia\u2010Pacific region, 1998\u20132002"],"prefix":"10.1111","volume":"12","author":[{"given":"JOHN H","family":"STEWART","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARGARET RE","family":"MCCREDIE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHEILA M","family":"WILLIAMS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KITTY J","family":"JAGER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LILYANNA","family":"TRPESKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"STEPHEN P","family":"MCDONALD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"FOR THE ESRD INCIDENCE STUDY GROUP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,8,14]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","unstructured":"RuggenentiP SchieppatiA RemuzziG.Progression remission regression of chronic renal diseases.Lancet2001;357:1601\u20138.","DOI":"10.1016\/S0140-6736(00)04728-0"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","unstructured":"WolfeRA HeldPJ Hulbert\u2010ShearonTA AgodoaLYC PortFK.A critical examination of trends in outcome over the last decade.Am. J. Kidney Dis.1998;32(Suppl 4):S9\u201315.","DOI":"10.1016\/S0272-6386(98)70157-X"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","unstructured":"StewartJH McCredieMRE WilliamsSM McDonaldSP.Interpreting incidence trends for treated end\u2010stage renal disease: Implications for evaluating disease control in Australia.Nephrology2004;9:238\u201346.","DOI":"10.1111\/j.1440-1797.2004.00259.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","unstructured":"StengelB BillonS Van DijkPCWet\u2003al.Trends in the incidence of renal replacement therapy for end\u2010stage renal disease in Europe 1990\u20131999.Nephrol. Dial. Transplant.2003;18:1824\u201333.","DOI":"10.1093\/ndt\/gfg233"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","unstructured":"Van DijkPCW JagerKJ StengelB Gr\u00f6nhagen\u2010RiskaC FeestTG BriggsJD.Renal replacement therapy for diabetic end\u2010stage renal disease: Data from ten registries in Europe (1991\u20132000).Kidney Int.2005;67:1489\u201399.","DOI":"10.1111\/j.1523-1755.2005.00227.x"},{"key":"e_1_2_6_7_2","unstructured":"US Renal Data System.USRDS 2004 Annual Data Report: Atlas of End\u2010Stage Renal Disease in the United States. Bethesda MD:National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases 2004."},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","unstructured":"WakaiK NakaiS KikuchiKet\u2003al.Trends in incidence of end\u2010stage renal disease in Japan 1983\u20132000: Age\u2010adjusted and age\u2010specific rates by gender and cause.Nephrol. Dial. Transplant.2004;19:2044\u201352.","DOI":"10.1093\/ndt\/gfh317"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","unstructured":"PernegerTV KlagMJ FeldmanHI WheltonPK.Projections of hypertension\u2010related renal disease in middle\u2010aged residents of the United States.JAMA1993;269:1272\u20137.","DOI":"10.1001\/jama.1993.03500100070030"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","unstructured":"The ESRD Incidence Study Group.Geographic ethnic age\u2010related and temporal variation in the incidence of end\u2010stage renal disease in Europe Canada and the Asia\u2010Pacific region 1998\u20132002.Nephrol. Dial. Transplant.2006;21:2178\u201383.","DOI":"10.1093\/ndt\/gfl145"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/jech.50.3.334"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2004.00258.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70316-7"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.04.067"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2006.01986.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000067420.83632.C1"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/18.3.552"},{"key":"e_1_2_6_18_2","first-page":"1092","article-title":"Diabetes mellitus prevalence among dialysed patients in France (UREMIDIAB Study)","volume":"7","author":"Zmirou D","year":"1992","journal-title":"Nephrol. Dial. Transplant."},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051309"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2001.00630.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.14.1782"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-200107000-00006"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00834.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66583-X"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-92-6-776"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198209093071104"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.6.1236"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00265.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.4.518"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.9.1278"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.5.829"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.1.76"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.12.2985"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000159"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2006.00616.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2006.00617.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.9.1584"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1159\/000095329"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050616"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199712)14:5 <S7::AID-DIA522>3.3.CO;2-I"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.19.2519"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.09709.x"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.63.s83.14.x"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.63.s83.2.x"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1797.2001.00029.x"}],"container-title":["Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1797.2007.00830.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1797.2007.00830.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T23:34:32Z","timestamp":1744414472000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1797.2007.00830.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,14]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1440-1797.2007.00830.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1797.2007.00830.x","archive":["Portico"],"relation":{},"ISSN":["1320-5358","1440-1797"],"issn-type":[{"value":"1320-5358","type":"print"},{"value":"1440-1797","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,14]]},"assertion":[{"value":"2007-08-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}